查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953882

獸用整形外科藥物市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、動物類型、給藥途徑、最終用途、地區和競爭格局分類，2021-2031年

Veterinary orthopedic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product Type, By Animal type, By Route of Administration, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸用整形外科藥物市場預計將從 2025 年的 42.3 億美元成長到 2031 年的 66.8 億美元，複合年成長率為 7.91%。

該領域涵蓋動物肌肉骨骼問題的外科和藥物治療，重點在於骨折修復、關節疾病治療和韌帶損傷癒合，旨在減輕疼痛並恢復運動功能。推動這一領域發展的主要因素是寵物人性化的趨勢日益增強。將寵物視為家庭成員的飼主往往更積極地投入資金進行復健治療。此外，老年寵物肥胖率的上升也增加了對骨關節炎和其他退化性關節疾病的醫療干預需求。

市場概覽
預測期 2027-2031
市場規模：2025年 42.3億美元
市場規模：2031年 66.8億美元
複合年成長率：2026-2031年 7.91%
成長最快的細分市場 黏度補充劑
最大的市場 北美洲

儘管有這些積極跡象，但複雜手術和術後復原的高昂費用仍然是市場成長的主要障礙。這些高昂的費用往往使預算有限或沒有保險的寵物飼主難以負擔專業的整形外科治療。根據美國寵物用品協會（APPA）的數據，2024年犬飼主在外科獸醫護理方面的平均年度支出為458美元。這項統計數據凸顯了經濟障礙的存在，這些障礙限制了寵物獲得昂貴的整形外科手術的機會，並可能阻礙整個市場的擴張。

市場促進因素

寵物健康保險的快速成長是全球獸用整形外科藥物市場的主要驅動力，因為它降低了複雜外科手術的經濟門檻。由於全髖關節置換術和脛骨平台水平截骨術（TPLO）等治療費用昂貴，保險提供了一張至關重要的安全網，使飼主能夠核准治療，而不是選擇安樂死或保守治療。根據北美寵物健康保險協會（NAPHIA）2024年5月發布的產業趨勢報告，2023年北美地區的保費總額達到42.7億美元。這種經濟支持使獸醫能夠提案建議的治療方案，而不會因為費用問題而立即被拒絕。同時，英國保險協會（ABI）報告稱，2024年的賠償額將達到創紀錄的10億英鎊，這表明有充足的資金支持專業整形外科中心的發展。

同時，可支配收入的成長和獸醫醫療費用支出的增加刺激了對先進肌肉骨骼治療的需求，從而推動了市場成長。寵物飼主越來越重視愛犬的壽命和健康，因此在高品質整形外科植入和專業醫療服務方面的支出也隨之增加。這種經濟基礎為先進生物療法和個人化解決方案的推廣應用創造了有利環境。根據美國寵物用品協會 (APPA) 2024 年 3 月發布的《產業趨勢》報告，2023 年美國寵物產業總支出達 1,470 億美元。這筆資金的流入使獸醫院能夠投資先進的診斷設備和儀器，提高其處理複雜整形外科病例的能力，並帶動藥品和醫療設備市場的擴張。

市場挑戰

先進的外科手術和術後復健的高昂費用是全球獸用整形外科藥物市場的主要障礙。這些高昂的治療費用構成了巨大的經濟負擔，迫使飼主選擇費用較低的安寧療護。面對昂貴的重建手術和保守治療之間的選擇，預算緊張的飼主往往會放棄專業的治療。這種經濟上的猶豫直接導致手術數量的減少，從而限制了手術器械和整形外科植入製造商的商機。

獸醫費用的急劇上漲進一步加劇了這一困境，其漲幅往往超過整體通貨膨脹率，並擴大了經濟負擔。英國保險協會在2024年報告稱，寵物保險的平均理賠金額已升至685英鎊，而複雜的整形外科治療，例如肘關節發育不良，費用可能高達5萬英鎊。如此高昂的費用凸顯了未投保寵物飼主面臨的嚴重財務風險。因此，整形外科解決方案的市場僅限於小規模的客戶群，例如用戶和富裕人士，這實際上限制了該行業進一步擴張的潛力。

市場趨勢

單株抗體（mAb）療法的廣泛應用正在改變獸醫整形外科疼痛管理方式，它提供了一種靶向性強、每月一次的治療方案，可取代每日非類固醇消炎劑。與可能導致肝腎毒性的傳統藥物不同，這些生物製藥特異性抑制神經生長因子，從而緩解骨關節炎疼痛，並顯著提高安全性。隨著獸醫在長期慢性病治療中越來越傾向於使用這些注射劑而非標準口服藥物，向物種特異性生物製藥的技術轉型正在為該行業帶來可觀的收入。在2025年2月發布的2024年度報告中，碩騰公司（Zoetis）公佈了93億美元的總收入，並將這一成功歸功於其貓狗骨關節炎疼痛產品在全球範圍內的強勁市場需求。

同時，生物製藥與再生醫學的深度融合正在推進，治療重點也從症狀控制轉向結構性組織修復。富血小板血漿（PRP）療法和異體幹細胞療法的創新，使醫療專業人員能夠透過調節發炎和促進軟骨再生來治療退化性關節疾病的根本原因。這一趨勢的驅動力在於，各方投入巨資，旨在克服供體獲取方面的傳統挑戰，並實現「即用型」生物製劑的標準化，使其能夠廣泛應用於臨床。例如，根據dvm360報道，Gallant 治療方法在2025年7月資金籌措，以加速其用於治療犬貓整形外科疾病的即用型間質幹細胞產品的商業化進程。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸用整形外科藥物市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（生物製藥、黏彈性替代品、藥品）
    • 依動物類型（狗、貓、馬、牛、豬、其他）
    • 給藥途徑（口服、注射、局部）
    • 透過申請（獸醫醫院/診所、居家醫療環境、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用整形外科藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸用整形外科藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸用整形外科藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲獸用整形外科藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲獸用整形外科藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸用整形外科藥物市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Enso Discoveries, LLC
  • Zoetis, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc
  • Biogenesis Bago SA
  • American Regent, Inc..
  • Merck & Co., Inc.
  • Vetoquinol SA
  • Ceva Sante Animale
  • Virbac SA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23849

The Global Veterinary Orthopedic Medicine Market is projected to expand from USD 4.23 Billion in 2025 to USD 6.68 Billion by 2031, reflecting a CAGR of 7.91%. This sector covers the surgical and pharmaceutical management of animal musculoskeletal issues, focusing on repairing fractures, treating joint diseases, and healing ligament injuries to reduce pain and restore movement. A major force behind this growth is the increasing trend of pet humanization, as owners who regard their animals as family members are more inclined to fund restorative treatments. Furthermore, rising obesity rates in aging pets are fueling the need for medical interventions to manage osteoarthritis and other degenerative joint disorders.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.23 Billion
Market Size 2031USD 6.68 Billion
CAGR 2026-20317.91%
Fastest Growing SegmentViscosupplements
Largest MarketNorth America

Despite these positive indicators, the significant expenses linked to complex surgeries and post-operative rehabilitation pose a major obstacle to market growth. These high costs often make specialized orthopedic care unattainable for pet owners with limited budgets or without insurance. Data from the American Pet Products Association indicates that in 2024, dog owners spent an average of $458 annually on surgical veterinary visits. This statistic underscores the economic hurdles that restrict the uptake of costly orthopedic procedures, potentially limiting the overall reach of the market.

Market Driver

The swift growth of pet health insurance serves as a key driver for the Global Veterinary Orthopedic Medicine Market by reducing financial obstacles to complex surgical procedures. Since interventions like total hip replacements and tibial plateau leveling osteotomy (TPLO) are expensive, insurance coverage offers a vital safety net that encourages owners to approve treatment rather than choosing euthanasia or conservative management. According to the North American Pet Health Insurance Association's May 2024 'State of the Industry Report', total premium volume in North America hit $4.27 billion in 2023. This financial support enables veterinarians to suggest preferred repair options without immediate dismissal due to cost, while the Association of British Insurers reported a record £1 billion in claims paid out in 2024, demonstrating the significant funds supporting specialized orthopedic centers.

Simultaneously, rising disposable income and increased spending on veterinary healthcare are reinforcing market growth by fueling demand for superior musculoskeletal treatments. Pet owners are placing greater importance on their animals' longevity and well-being, resulting in higher spending on premium orthopedic implants and specialized medical services. This economic readiness fosters an environment conducive to advanced biological therapies and customized solutions. The American Pet Products Association's March 2024 'State of the Industry' report noted that total U.S. pet industry expenditures reached $147 billion in 2023. This capital influx allows veterinary clinics to acquire advanced diagnostic tools and instrumentation, improving their ability to manage complex orthopedic cases and expanding the market for pharmaceuticals and medical devices.

Market Challenge

The considerable expense associated with advanced surgeries and post-surgical rehabilitation acts as a major impediment to the global veterinary orthopedic medicine market. High procedural costs establish a formidable economic hurdle, often forcing pet owners to decline necessary surgeries in favor of cheaper, palliative management strategies. When choosing between expensive restorative operations and conservative care, owners with budget constraints frequently refuse specialized treatment. This financial hesitation directly lowers the number of surgeries performed, thereby restricting revenue opportunities for producers of surgical instruments and orthopedic implants.

This difficulty is exacerbated by the rapid rise in veterinary medical costs, which frequently exceed general inflation rates and widen the affordability gap. In 2024, the Association of British Insurers reported that the average pet insurance claim increased to £685, with complex orthopedic treatments for issues like elbow dysplasia costing as much as £50,000. Such high costs highlight the severe financial risk for uninsured pet owners. As a result, the serviceable market for orthopedic solutions is limited to a smaller segment of insured or wealthy clients, effectively capping the industry's potential for broader expansion.

Market Trends

The extensive adoption of monoclonal antibody (mAb) therapies is transforming veterinary orthopedic pain management by providing a targeted, monthly substitute for daily non-steroidal anti-inflammatory drugs. In contrast to traditional medications that may cause hepatic or renal toxicity, these biological agents specifically block nerve growth factor to relieve osteoarthritis pain with a much better safety profile. This technical transition toward species-specific biologics is generating significant industry revenue, as veterinarians increasingly prefer these injectables over standard oral drugs for long-term chronic care. In its February 2025 '2024 Annual Report', Zoetis announced total revenue of $9.3 billion, attributing this success to the strong global adoption of its osteoarthritis pain products for cats and dogs.

At the same time, the market is seeing strong integration of biologics and regenerative medicine, shifting treatment focus from symptom control to structural tissue repair. Innovations in platelet-rich plasma and allogeneic stem cell therapies allow practitioners to treat the underlying causes of degenerative joint diseases by modulating inflammation and stimulating cartilage regeneration. This trend is bolstered by substantial investments designed to standardize these 'off-the-shelf' biological treatments for broad clinical application, overcoming earlier hurdles regarding donor sourcing. For instance, dvm360 reported in July 2025 that Gallant Therapeutics raised $18 million in Series B funding to speed up the commercialization of its ready-to-use mesenchymal stem cell products for canine and feline orthopedic conditions.

Key Market Players

  • Enso Discoveries, LLC
  • Zoetis, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc
  • Biogenesis Bago SA
  • American Regent, Inc..
  • Merck & Co., Inc.
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Virbac S.A.

Report Scope

In this report, the Global Veterinary Orthopedic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Orthopedic Medicine Market, By Product Type

  • Biologics
  • Viscosupplements
  • Pharmaceuticals

Veterinary Orthopedic Medicine Market, By Animal type

  • Canine
  • Feline
  • Equine
  • Cattle
  • Swine
  • Others

Veterinary Orthopedic Medicine Market, By Route of Administration

  • Oral
  • Parenteral
  • Topical

Veterinary Orthopedic Medicine Market, By End Use

  • Veterinary Hospitals and Clinics
  • Homecare Settings
  • Others

Veterinary Orthopedic Medicine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Orthopedic Medicine Market.

Available Customizations:

Global Veterinary Orthopedic Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Orthopedic Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Biologics, Viscosupplements, Pharmaceuticals)
    • 5.2.2. By Animal type (Canine, Feline, Equine, Cattle, Swine, Others)
    • 5.2.3. By Route of Administration (Oral, Parenteral, Topical)
    • 5.2.4. By End Use (Veterinary Hospitals and Clinics, Homecare Settings, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Orthopedic Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Animal type
    • 6.2.3. By Route of Administration
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Orthopedic Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Animal type
        • 6.3.1.2.3. By Route of Administration
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada Veterinary Orthopedic Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Animal type
        • 6.3.2.2.3. By Route of Administration
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico Veterinary Orthopedic Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Animal type
        • 6.3.3.2.3. By Route of Administration
        • 6.3.3.2.4. By End Use

7. Europe Veterinary Orthopedic Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Animal type
    • 7.2.3. By Route of Administration
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Orthopedic Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Animal type
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By End Use
    • 7.3.2. France Veterinary Orthopedic Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Animal type
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom Veterinary Orthopedic Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Animal type
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Veterinary Orthopedic Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Animal type
        • 7.3.4.2.3. By Route of Administration
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Veterinary Orthopedic Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Animal type
        • 7.3.5.2.3. By Route of Administration
        • 7.3.5.2.4. By End Use

8. Asia Pacific Veterinary Orthopedic Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Animal type
    • 8.2.3. By Route of Administration
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Orthopedic Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Animal type
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Veterinary Orthopedic Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Animal type
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan Veterinary Orthopedic Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Animal type
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea Veterinary Orthopedic Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Animal type
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Veterinary Orthopedic Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Animal type
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By End Use

9. Middle East & Africa Veterinary Orthopedic Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Animal type
    • 9.2.3. By Route of Administration
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Orthopedic Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Animal type
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE Veterinary Orthopedic Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Animal type
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa Veterinary Orthopedic Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Animal type
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By End Use

10. South America Veterinary Orthopedic Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Animal type
    • 10.2.3. By Route of Administration
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Orthopedic Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Animal type
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia Veterinary Orthopedic Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Animal type
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina Veterinary Orthopedic Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Animal type
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Orthopedic Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Enso Discoveries, LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Zoetis, Inc.
  • 15.3. Boehringer Ingelheim International GmbH
  • 15.4. Elanco Animal Health Inc
  • 15.5. Biogenesis Bago SA
  • 15.6. American Regent, Inc..
  • 15.7. Merck & Co., Inc.
  • 15.8. Vetoquinol S.A.
  • 15.9. Ceva Sante Animale
  • 15.10. Virbac S.A.

16. Strategic Recommendations

17. About Us & Disclaimer